Research and Development

New findings from Public Health England (PHE)’s Heart Age Test indicate that around 10% of men in the UK are …

The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …

Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …

Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …

A team of researchers at Dutch immunotherapy research firm Merus have developed an approach to efficiently manufacture bispecific antibodies which …

The FDA has announced that it has granted an accelerated approval for the use of benznidazole in children between the ages …

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …

The September edition of Pharmafocus is now available – click here to read online.